InvestorsObserver
Sign Up Login

PNT POINT Biopharma Global Inc.

$6.71 $-0.03 (-0.37%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

PNT Stock Analysis Overview

What this means: POINT Biopharma Global Inc. (PNT) gets an Overall Rank of 65, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PNT's 65 means that it ranks higher than 65% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

PNT Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

PNT Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

PNT Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

PNT Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

PNT Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

PNT Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

PNT Stock Analysis Overview

What this means: POINT Biopharma Global Inc. (PNT) gets an Overall Rank of 65, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PNT's 65 means that it ranks higher than 65% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full PNT report

PNT Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

PNT Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

PNT Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

PNT Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

PNT Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

PNT Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

POINT Biopharma Global Inc. (PNT) Analyst Forecast

PNT Price, Volume, Earnings, and Dividend Date

  • Last Price $6.71
  • Previous Close $6.73
  • Change $-0.03
  • Open $6.69
  • Volume 206,345
  • Avg. Volume (100-day) 766,941
  • Market Cap 710,989,107
  • Days Range 6.68 - 6.82
  • 52-week Range 4.25 - 10.98
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 02/12/23
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 1.915
  • PEG Ratio —

POINT Biopharma Global Inc. (PNT) Company Description

POINT Biopharma Global Inc is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.

POINT Biopharma Global Inc. (PNT) Stock Chart

View Interactive PNT chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Compass Therapeutics Inc. (CMPX) (CMPX) $4.45
Oncolytics Biotech Inc. (ONCY) (ONCY) $1.74
Oyster Point Pharma Inc. (OYST) (OYST) $11.15
VectivBio Holding AG (VECT) (VECT) $7.80
Verona Pharma plc (VRNA) (VRNA) $12.22
GlycoMimetics Inc. (GLYC) (GLYC) $2.45
Provention Bio Inc. (PRVB) (PRVB) $9.00
scPharmaceuticals Inc. (SCPH) (SCPH) $6.69
Galera Therapeutics Inc. (GRTX) (GRTX) $1.69
Astria Therapeutics Inc. (ATXS) (ATXS) $10.79